Edition:
United States

People: C R Bard Inc (BCR)

BCR on New York Consolidated

315.98USD
22 Jun 2017
Change (% chg)

$0.98 (+0.31%)
Prev Close
$315.00
Open
$314.84
Day's High
$316.35
Day's Low
$314.83
Volume
614,296
Avg. Vol
879,677
52-wk High
$316.80
52-wk Low
$203.63

Ring, Timothy 

Mr. Timothy M. Ring is Chairman of the Board, Chief Executive Officer of the Company. Mr. Ring has served as Chairman and Chief Executive Officer of the Company since August 2003, having been Group President from April 1997 to August 2003, Group Vice President from December 1993 to April 1997 and Vice President-Human Resources from June 1992 to December 1993. He is also a director of Quest Diagnostics Incorporated. Mr. Ring has been nominated to serve an additional term as a director due to his prior service on C. R. Bard’s Board and more than 20 years of experience in various leadership capacities at C. R. Bard, including as the Company’s Chairman and Chief Executive Officer. He was previously responsible for the Company’s global Vascular and Specialty Access businesses. Mr. Ring has been instrumental in developing and implementing C. R. Bard’s current strategic direction. Prior to joining the Company, he gained valuable experience in leadership roles at Abbott Laboratories in both human resources and general management. Mr. Ring is a Trustee of the Foundation of The University of Medicine & Dentistry of New Jersey. He holds a B.S. in Industrial and Labor Relations from Cornell University.

Basic Compensation

Total Annual Compensation, USD 1,092,000
Restricted Stock Awards, USD 5,246,730
Long-Term Incentive Plans, USD --
All Other, USD 6,287,770
Fiscal Year Total, USD 12,626,500

Options Compensation

  Quantity Market Value
Exercisable 885,473 30,171,800.00
Unexercisable 416,125 7,992,630.00
Exercised 202,293 28,920,600.00
Name Fiscal Year Total

Timothy Ring

12,626,500

John Weiland

7,121,000

James Beasley

4,290,960

Timothy Collins

4,309,940

John Groetelaars

--

Christopher Holland

3,949,350
As Of  30 Dec 2016